SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Gufic Biosciences informs about disclosure

26 Oct 2019 Evaluate

In continuation of its earlier letter dated 24th October, 2019, regarding the admission of petition by the National Company Law Tribunal (NCLT), Mumbai Bench, in order dated 22.10.2019 the certified copy of which was received by the Company on 23.10.2019, filed by one of the Operational Creditors, Scorpion Express (Scorpion), Gufic Biosciences has informed that the company and Scorpion have reached a settlement. The agreement of settlement has been signed on 25.10.2019 between both the parties and accordingly Scorpion will file an application for withdrawal of the petition before the NCLT. As the NCLT is on vacation, the said application for withdrawal shall be made after NCLT will resume, on or after 04.11.2019.

The above information is a part of company’s filings submitted to BSE.

Gufic Biosciences Share Price

301.30 -1.35 (-0.45%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×